Dr. Chao H. Huang
Claim this profileUniversity of Kansas Health System Saint Francis Campus
About Chao H. Huang
Education:
- Completed preparatory studies at Colegio Rosario, Porto Alegre, Rio Grande do Sul.
- Earned an MD from Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul.
Experience:
- Completed an Internship and Residency in Internal Medicine at Presbyterian Medical Center of the University of Pennsylvania Health System, Philadelphia, PA.
- Undertook a Clinical Fellowship in Hematology & Medical Oncology at Fox Chase Cancer Center and Temple University Hospital.
- Actively involved in teaching and mentoring at the University of Kansas Health System Saint Francis Campus, specializing in lung cancer and head and neck cancer.
Area of expertise
Lung Cancer
Chao H. Huang has run 19 trials for Lung Cancer. Some of their research focus areas include:
Non-Small Cell Lung Cancer
Chao H. Huang has run 14 trials for Non-Small Cell Lung Cancer. Some of their research focus areas include:
Affiliated Hospitals
University Of Kansas Health System Saint Francis Campus
University Of Kansas Cancer Center-Overland Park
Clinical Trials Chao H. Huang is currently running
Chemotherapy + Immunotherapy vs. Immunotherapy
for Advanced Lung Cancer
This phase III trial compares the effect of adding chemotherapy to immunotherapy (pembrolizumab) versus immunotherapy alone in treating patients with stage IIIB-IV lung cancer. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab and chemotherapy may help stabilize lung cancer.
Recruiting
2 awards
Phase 3
Atezolizumab + Pirfenidone
for Non-Small Cell Lung Cancer
The purpose of this study is to see if adding pirfenidone to atezolizumab will increase anti tumor activity and reduce treatment resistance in stage 4 and recurrent non- small cell lung cancer participants.
Recruiting
1 award
Phase 1 & 2
14 criteria
More about Chao H. Huang
Clinical Trial Related
6 years of experience running clinical trials · Led 22 trials as a Principal Investigator · 7 Active Clinical Trials
Treatments Chao H. Huang has experience with
- Pembrolizumab
- Carboplatin
- Pemetrexed
- Ramucirumab
- Biospecimen Collection
- Selpercatinib
Breakdown of trials Chao H. Huang has run
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Chao H. Huang specialize in?
Chao H. Huang focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Chao H. Huang currently recruiting for clinical trials?
Yes, Chao H. Huang is currently recruiting for 7 clinical trials in Topeka Kansas. If you're interested in participating, you should apply.
Are there any treatments that Chao H. Huang has studied deeply?
Yes, Chao H. Huang has studied treatments such as Pembrolizumab, Carboplatin, Pemetrexed.
What is the best way to schedule an appointment with Chao H. Huang?
Apply for one of the trials that Chao H. Huang is conducting.
What is the office address of Chao H. Huang?
The office of Chao H. Huang is located at: University of Kansas Health System Saint Francis Campus, Topeka, Kansas 66606 United States. This is the address for their practice at the University of Kansas Health System Saint Francis Campus.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.